Pain, analgesia, and sex
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue
Abstract
There is a large volume of data regarding sex differences in pain sensitivity and analgesia in both animals and in humans. It is difficult to analyze all the complex observations and find new aims for future studies. The main aspects of sex differences in sensitivity to and analgesia of experimental and clinical pain are described in this paper. The most important parameters which influence sex differences in pain perception are also presented.
Authors and Affiliations
Katarzyna Romanowska
Keywords
Related Articles
- EP ID EP66347
- DOI -
- Views 170
- Downloads 0
The other face of MUC1 protein in cancer progression – the role of MUC1-C subunit
MUC1 is high-molecular-weight glycoprotein which is widely expressed on epithelial cell layers of various organs and is aberrantly overexpressed in most human carcinomas such as breast, ovarian or colon cancer. MUC1 cont...
Dziąsło jako nowe źródło komórek macierzystych w obrębie jamy ustnej o dużej dostępności i o potencjalnym znaczeniu w leczeniu regeneracyjnym
Od odkrycia komórek macierzystych szpiku kostnego (BMMSCs) wielu badaczy skoncentrowało się na poszukiwaniu innych, łatwiej dostępnych źródeł mezenchymalnych komórek macierzystych (MSCs). Odnaleziono i wyizolowano komórk...
Arsenic trioxide preferentially induces nonapoptotic cell deaths as well as actin cytoskeleton rearrangement in the CHO AA8 cell line
Introduction: The therapeutic effect of arsenic trioxide (ATO, As2O3) has been investigated for many years. However, the precise molecular mechanisms underlying the antitumor activity of ATO are still not fully understoo...
Expression and activity of SNAIL transcription factor during Epithelial to Mesenchymal Transition (EMT) in cancer progression
Inhibition of E-cadherin gene expression by transcription factor SNAIL is known to be a crucial element of Epithelial to Mesenchymal Transition; EMT. Epigenetic regulation of E-cadherin expression is regulated by SNAIL b...
Terapia antycytokinowa łuszczycy – nie tylko blokery TNF‑α. Przegląd piśmiennictwa na temat skuteczności terapii inhibitorami IL‑12/IL‑23 oraz limfocytów T i B